SA113340239B1 - تركيبة واستخدامها في معالجة صدوع الشرج - Google Patents

تركيبة واستخدامها في معالجة صدوع الشرج Download PDF

Info

Publication number
SA113340239B1
SA113340239B1 SA113340239A SA113340239A SA113340239B1 SA 113340239 B1 SA113340239 B1 SA 113340239B1 SA 113340239 A SA113340239 A SA 113340239A SA 113340239 A SA113340239 A SA 113340239A SA 113340239 B1 SA113340239 B1 SA 113340239B1
Authority
SA
Saudi Arabia
Prior art keywords
composition
extract
anal
hibiscus
protein
Prior art date
Application number
SA113340239A
Other languages
Arabic (ar)
English (en)
Inventor
باستيا فيليبو
ساكومانو ماوريزيو
Original Assignee
تى اتش دى اس.بى.ايه.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46001672&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SA113340239(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by تى اتش دى اس.بى.ايه. filed Critical تى اتش دى اس.بى.ايه.
Publication of SA113340239B1 publication Critical patent/SA113340239B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A61K36/5775—Hibiscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SA113340239A 2012-01-30 2013-01-27 تركيبة واستخدامها في معالجة صدوع الشرج SA113340239B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2012/000027 WO2013114410A1 (en) 2012-01-30 2012-01-30 A composition and use thereof in the treatment of anal rhagades

Publications (1)

Publication Number Publication Date
SA113340239B1 true SA113340239B1 (ar) 2015-07-07

Family

ID=46001672

Family Applications (1)

Application Number Title Priority Date Filing Date
SA113340239A SA113340239B1 (ar) 2012-01-30 2013-01-27 تركيبة واستخدامها في معالجة صدوع الشرج

Country Status (23)

Country Link
US (1) US9345747B2 (en:Method)
EP (1) EP2646039B1 (en:Method)
JP (1) JP5903505B2 (en:Method)
KR (1) KR101599447B1 (en:Method)
CN (2) CN109865000A (en:Method)
AU (1) AU2012368815B2 (en:Method)
BR (1) BR112014018850A8 (en:Method)
CA (1) CA2863369C (en:Method)
DK (1) DK2646039T3 (en:Method)
ES (1) ES2485490T3 (en:Method)
HR (1) HRP20140594T1 (en:Method)
IL (1) IL233875A (en:Method)
IN (1) IN2014MN01733A (en:Method)
MX (1) MX336204B (en:Method)
PL (1) PL2646039T3 (en:Method)
RS (1) RS53457B (en:Method)
RU (1) RU2580622C2 (en:Method)
SA (1) SA113340239B1 (en:Method)
SG (1) SG11201404413UA (en:Method)
SI (1) SI2646039T1 (en:Method)
TW (1) TWI495476B (en:Method)
WO (1) WO2013114410A1 (en:Method)
ZA (1) ZA201405208B (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015100118A1 (en) 2013-12-24 2015-07-02 The Procter & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
ITRM20150163A1 (it) * 2015-04-17 2016-10-17 Uniderm Farm S R L Composizioni farmaceutiche per il trattamento delle ragadi anali
US10117826B2 (en) 2016-03-31 2018-11-06 Peter Angia Pham Bodily lubricating and moisturizing compositions containing plant mucilage
US10835504B2 (en) 2018-04-18 2020-11-17 G&S Laboratories, Inc. Compositions to treat anal itch
EP3787654A4 (en) * 2018-05-02 2022-04-20 Montero Gida Sanayi Ve Ticaret Anonim Sirketi TOPICAL COMPOSITIONS FOR STRETCH MARKS ON THE SKIN
RU2771015C2 (ru) * 2020-09-25 2022-04-25 Общество с ограниченной ответственностью "ФАРМКОММ" Фармацевтическая композиция в виде мази для лечения геморроя

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
AU7340098A (en) * 1997-04-16 1998-11-11 Laboratoires Serobiologiques (Societe Anonyme) Use in cosmetics of a protein fraction extracted from okra seeds
US6379719B1 (en) * 1998-04-08 2002-04-30 Laboratories Serobiologiques (Societe Anonyme) Use of at least one protein fraction extracted from Hibiscus esculentus seeds and cosmetic composition containing such a fraction
CN1233469A (zh) * 1998-04-28 1999-11-03 王京杭 组织修复促进剂
US6956120B2 (en) * 2000-11-09 2005-10-18 Yasushi Onaka β-1.3-1.6 glucan (Aureobasidium medium)
JP2002204687A (ja) * 2000-11-09 2002-07-23 Onaka Yasushi β−1.3−1.6グルカン(アウレオバシジウム培養液)の医療、保健、福祉、食品および各種産業分野での応用
JP2003104832A (ja) * 2001-09-28 2003-04-09 Chifure Keshohin:Kk 皮膚外用剤
JP4544500B2 (ja) 2002-07-19 2010-09-15 一丸ファルコス株式会社 ヒアルロン酸合成促進剤
PT1620469E (pt) * 2003-05-02 2013-05-07 Ceapro Inc Método melhorado de extração e purificação para cereal -glucano
RU2277920C2 (ru) * 2004-02-24 2006-06-20 Государственное Учреждение "Пятигорский Государственный Научно-Исследовательский Институт Курортологии Министерства Здравоохранения Российской Федерации" Способ лечения детей, больных хроническим вирусным гепатитом, с применением сульфидных ванн и слабоуглекислой минеральной водой
ITMI20042111A1 (it) * 2004-11-04 2005-02-04 Biofarmitalia Spa Cerotto contenenti una sostanza scelta tra i catrami aventi caratteristiche riducenti in dermatologia
JP5048935B2 (ja) * 2005-08-24 2012-10-17 株式会社ヤクルト本社 保湿剤
DE202007004856U1 (de) * 2007-04-01 2007-06-06 Rühle, Wilfried, Dipl.-Ing. CHM Anti Aging Komplex
CN101095482B (zh) * 2007-07-05 2012-02-15 中国科学院长春应用化学研究所 制备膳食纤维食品用大麦麦麸或燕麦麦麸的制法
US20090202664A1 (en) * 2008-02-11 2009-08-13 Svetislav Mikalacki Herbal cream or oil for the treatment hemorroids and wounds
ITUD20100112A1 (it) * 2010-06-09 2011-12-10 Farma Derma S R L Preparazione per uso vaginale e rettale e relativo procedimento di produzione
CN102084963A (zh) * 2010-09-29 2011-06-08 吉林省农业机械研究院 一种制备燕麦麦麸膳食纤维食品的方法

Also Published As

Publication number Publication date
JP2015504915A (ja) 2015-02-16
RU2014129391A (ru) 2016-03-27
ZA201405208B (en) 2015-10-28
MX2014009244A (es) 2015-03-19
IN2014MN01733A (en:Method) 2015-07-10
BR112014018850A2 (en:Method) 2017-06-20
CN109865000A (zh) 2019-06-11
BR112014018850A8 (pt) 2017-07-11
CN104114177A (zh) 2014-10-22
SI2646039T1 (sl) 2014-10-30
WO2013114410A1 (en) 2013-08-08
AU2012368815B2 (en) 2018-03-01
TW201334787A (zh) 2013-09-01
DK2646039T3 (da) 2014-08-11
MX336204B (es) 2016-01-11
IL233875A0 (en) 2014-09-30
SG11201404413UA (en) 2014-10-30
KR20140127296A (ko) 2014-11-03
RS53457B (sr) 2014-12-31
HK1186378A1 (en) 2014-03-14
US20140303094A1 (en) 2014-10-09
AU2012368815A1 (en) 2014-09-18
US9345747B2 (en) 2016-05-24
ES2485490T3 (es) 2014-08-13
CA2863369A1 (en) 2013-08-08
HRP20140594T1 (hr) 2014-10-24
JP5903505B2 (ja) 2016-04-13
TWI495476B (zh) 2015-08-11
CA2863369C (en) 2020-03-10
EP2646039B1 (en) 2014-05-14
IL233875A (en) 2017-01-31
RU2580622C2 (ru) 2016-04-10
EP2646039A1 (en) 2013-10-09
KR101599447B1 (ko) 2016-03-14
PL2646039T3 (pl) 2014-10-31

Similar Documents

Publication Publication Date Title
US9962402B2 (en) Healing composition for topical application
JP5897164B2 (ja) 外用組成物
TWI495476B (zh) 用於治療肛門皸裂之組成物及其用途
CN114699508A (zh) 一种硅酮凝胶及其制备方法和应用
US10960011B2 (en) Compositions for the treatment of ischemic ulcers and stretch marks
WO2024073011A1 (en) Topical compositions and methods for the treatment of dermal and transdermal fibrotic diseases, disorders and associated pain and inflammation
EP3461490B1 (en) Pharmaceutical composition for treating hemorrhoidal disaese
ES2958970T3 (es) Composiciones para uñas con propiedades antifúngicas
WO2024073013A1 (en) Combination treatment of dermal and transdermal fibrotic diseases, disorders and associated pain and inflammation
JP2016033137A (ja) 裂肛の治療における組成物及びその使用
TW202200208A (zh) 治療的新用途及方法
EP4110360A1 (en) Formulation based on natural ingredients for use in treating proctological disorders
ROCHER EPITOME OF CURRENT
HK1186378B (en) A composition and use thereof in the treatment of anal rhagades
BR102017008940A2 (pt) composição hidratante para estruturas queratinosas, uso da composição e caneta aplicadora.
EP2845591A1 (en) Use of trifluoroacetic acid as keratolytic agent to treat hyperkeratotic skin lesions
UA17116U (en) Method for preventing postoperative complications in surgical dentistry
BR102014032153B1 (pt) composição correlata, cosmética ou farmacêutica à base de ácido hialurônico para uso vaginal e seu método de preparação